To Evaluate the Visual Performance After Bilateral Implantation of Multifocal Intraocular Lenses
NCT ID: NCT03223857
Last Updated: 2019-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2013-04-09
2019-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Outcomes of a Segmental Refractive Multifocal Intraocular Lens
NCT03452969
Visual Acuity After the Combined Binocular Implantation of +2.75 Diopters and +3.25 Diopters Tecnis Multifocal Intraocular Lenses.
NCT02633072
Clinical Study to Evaluate the Visual Performance of Three Multifocal IOLs
NCT02990689
Visual Performance With a Trifocal Intraocular Lens
NCT01605058
Visual Outcomes After Presbyopic Lens Exchange
NCT03790592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients who received bilateral implantation of a multifocal intraocular lens pre-enrollment were included consecutively. Exclusion criteria were previous ocular surgeries excluding cataract surgery and refractive lens exchange, regular corneal astigmatism of \>1.5 diopter, and ocular pathologies or corneal abnormalities. At 3 months postoperative examination included manifest refraction; monocular and binocular uncorrected (UCVA) and distance-corrected (DCVA) visual acuity in at far, intermediate at near distance (logMAR); slit-lamp examination. 3 months postoperatively defocus testing, binocular contrast sensitivity (CS) under photopic and mesopic conditions, and a questionnaire on subjective quality of vision, optical phenomena, and spectacle independence were performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Femtosecond-laser-assisted lens exchange
Bilateral implantation of multifocal intraocular lens (MIOL) following femtosecond-laser-assisted lens exchange
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a regular corneal astigmatism \< 1.5 D measured with Pentacam (Oculus, Wetzlar, Germany)
Exclusion Criteria
* ocular pathologies
* corneal abnormalities
* endothelial cell count below 2000/mm²
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Clinic Frankfurt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Myriam Böhm, MD
Professor Dr. med. Thomas Kohnen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Kohnen, Professor
Role: STUDY_CHAIR
Goethe University Clinic Frankfurt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of ophthalmology University clinic Frankfurt
Frankfurt am Main, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
102/13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.